Xtant Medical Holdings (XTNT) Share-based Compensation (2010 - 2025)
Xtant Medical Holdings (XTNT) posted quarterly Share-based Compensation of $600000.0 for Q3 2025, down 45.45% year-over-year from $1.1 million in Q3 2024, and down 25.0% quarter-over-quarter from $800000.0 in Q2 2025.
Xtant Medical Holdings (XTNT) Share-based Compensation (2010 - 2025) Analysis & Trends
Xtant Medical Holdings (XTNT) has reported Share-based Compensation for 16 consecutive years, with $600000.0 the latest figure, recorded in Q3 2025.
- In Q3 2025, Share-based Compensation fell 45.45% year-over-year to $600000.0; the TTM figure through Sep 2025 stood at $3.0 million (down 28.11% YoY), while the FY2024 annual figure was $4.1 million, up 37.23% from the prior year.
- Share-based Compensation declined to $600000.0 in Q3 2025 per XTNT's latest filing, from $800000.0 in the prior quarter.
- Across five years, Share-based Compensation topped out at $3.6 million in Q3 2023 and bottomed at $456000.0 in Q1 2021.
- Historically, Share-based Compensation has averaged $996421.1 across 5 years, with a median of $758000.0 in 2025.
- Annual changes were most pronounced in 2023 — Share-based Compensation soared 461.62% — and 2024, when it plunged 69.44%.
- Xtant Medical Holdings' Share-based Compensation stood at $708000.0 in 2021, then declined by 9.75% to $639000.0 in 2022, then jumped by 46.79% to $938000.0 in 2023, then slipped by 12.9% to $817000.0 in 2024, then dropped by 26.56% to $600000.0 in 2025.
- Business Quant data shows XTNT's Share-based Compensation at $600000.0 in Q3 2025, $800000.0 in Q2 2025, and $758000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 7.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 87.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 42.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 39.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 45.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 94.15 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 12.80 Mn |
| 10 | Xtant Medical Holdings | 46.53 Mn | 28.93 Mn | 17.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 600,000.00 |
| Sep 30, 2025 | 600,000.00 |
| Jun 30, 2025 | 800,000.00 |
| Jun 30, 2025 | 800,000.00 |
| Mar 31, 2025 | 758,000.00 |
| Mar 31, 2025 | 758,000.00 |
| Dec 31, 2024 | 817,000.00 |
| Dec 31, 2024 | 817,000.00 |
| Sep 30, 2024 | 1.10 Mn |
| Sep 30, 2024 | 1.10 Mn |
| Jun 30, 2024 | 1.20 Mn |
| Jun 30, 2024 | 1.20 Mn |
| Mar 31, 2024 | 900,000.00 |
| Mar 31, 2024 | 900,000.00 |
| Dec 31, 2023 | 938,000.00 |
| Dec 31, 2023 | 938,000.00 |
| Sep 30, 2023 | 3.60 Mn |
| Sep 30, 2023 | 3.60 Mn |
| Jun 30, 2023 | 1.50 Mn |
| Jun 30, 2023 | 1.50 Mn |